Literature DB >> 3315616

Deacylation studies in vitro on anisoylated plasminogen streptokinase activator complex.

H Ferres1, M Hibbs, R A Smith.   

Abstract

Mesh：

Substances：

Year:  1987        PMID： 3315616     DOI： 10.2165/00003495-198700333-00011

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  5 in total

1.  Acyl-enzymes as thrombolytic agents in a rabbit model of venous thrombosis.

Authors:  R A Smith; R J Dupe; P D English; J Green
Journal:  Thromb Haemost       Date:  1982-06-28       Impact factor: 5.249

2.  Mechanism of protein stabilization by glycerol: preferential hydration in glycerol-water mixtures.

Authors:  K Gekko; S N Timasheff
Journal:  Biochemistry       Date:  1981-08-04       Impact factor: 3.162

3.  [Bolus injection of anisoylated plasminogen-streptokinase activator complex (BRL 26921) as an alternative concept of systemic lysis in acute myocardial infarct].

Authors:  P Doenecke; H Schwerdt; P Hellstern; E Wenzel; L Bette
Journal:  Klin Wochenschr       Date:  1986-08-01

4.  Clinical effects and kinetic properties of intravenous APSAC--anisoylated plasminogen-streptokinase activator complex (BRL 26921) in acute myocardial infarction.

Authors:  M Been; D P de Bono; A L Muir; F E Boulton; R Fears; R Standring; H Ferres
Journal:  Int J Cardiol       Date:  1986-04       Impact factor: 4.164

5.  Fibrinolysis with acyl-enzymes: a new approach to thrombolytic therapy.

Authors:  R A Smith; R J Dupe; P D English; J Green
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962
  5 in total
  6 in total

Review 1.  Prodrugs.

Authors:  D G Waller; C F George
Journal:  Br J Clin Pharmacol       Date:  1989-11       Impact factor: 4.335

2.  Consequences of antibody binding in vitro on the pharmacological properties of anisoylated plasminogen streptokinase activator complex.

Authors:  R Fears; H Ferres; M Hibbs; R Standring
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 3.  Preclinical pharmacological evaluation of anisoylated plasminogen streptokinase activator complex.

Authors:  H Ferres
Journal:  Drugs       Date:  1987       Impact factor: 9.546

4.  A comparison of the pharmacokinetic properties of streptokinase and anistreplase in acute myocardial infarction.

Authors:  J D Gemmill; K J Hogg; J M Burns; A P Rae; F G Dunn; R Fears; H Ferres; R Standring; H Greenwood; D Pierce
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

Review 5.  Pharmacokinetic optimisation of the treatment of embolic disorders.

Authors:  D M Lutomski; M Bottorff; K Sangha
Journal:  Clin Pharmacokinet       Date:  1995-01       Impact factor: 6.447

6.  Pre-dosing antibody levels and efficacy of thrombolytic drugs containing streptokinase.

Authors:  J D Gemmill; K J Hogg; F G Dunn; A P Rae; W S Hillis
Journal:  Br Heart J       Date:  1994-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.